Compare CVRX & ACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVRX | ACH |
|---|---|---|
| Founded | 2000 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.3M | 68.4M |
| IPO Year | 2021 | 2001 |
| Metric | CVRX | ACH |
|---|---|---|
| Price | $2.57 | $0.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $10.50 | $3.38 |
| AVG Volume (30 Days) | 541.2K | ★ 1.0M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.02 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $56,651,000.00 | ★ $2,762,032,000.00 |
| Revenue This Year | $17.17 | N/A |
| Revenue Next Year | $17.69 | $4.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.45 | N/A |
| 52 Week Low | $2.20 | $0.66 |
| 52 Week High | $11.30 | $4.69 |
| Indicator | CVRX | ACH |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 19.49 |
| Support Level | $2.20 | N/A |
| Resistance Level | $3.19 | $1.26 |
| Average True Range (ATR) | 0.19 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 9.68 | 1.78 |
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.